GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Dabomb Protein Biotech Corp (ROCO:6578) » Definitions » Research & Development

Dabomb Protein Biotech (ROCO:6578) Research & Development : NT$14.2 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Dabomb Protein Biotech Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Dabomb Protein Biotech's Research & Development for the three months ended in Mar. 2024 was NT$3.6 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was NT$14.2 Mil.

Dabomb Protein Biotech Research & Development Historical Data

The historical data trend for Dabomb Protein Biotech's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dabomb Protein Biotech Research & Development Chart

Dabomb Protein Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.29 14.15 11.82 11.85 13.59

Dabomb Protein Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.03 2.93 3.74 3.89 3.63

Dabomb Protein Biotech Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$14.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dabomb Protein Biotech  (ROCO:6578) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Dabomb Protein Biotech Research & Development Related Terms

Thank you for viewing the detailed overview of Dabomb Protein Biotech's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Dabomb Protein Biotech (ROCO:6578) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Dabomb Protein Biotech Corp (ROCO:6578) » Definitions » Research & Development
Comparable Companies
ROCO:6886 ROCO:4109 ROCO:2726 ROCO:1294 ROCO:2756 ROCO:6968 TPE:1220 ROCO:1271 TPE:1233 ROCO:6929 XSWX:NESN KHC GIS XPAR:BN SHSE:603288 NSE:NESTLEIND SZSE:300999 SHSE:600887 TSE:2802 LSE:ABF
Traded in Other Exchanges
N/A
Address
Number 52, Gongye 3rd Road, Annan District, Tainan, TWN, 709
Website
https://www.dabombprotein.com
Dabomb Protein Biotech Corp is a company specializing in antibiotic alternatives, and use postbiotics to boost immune strength and excel in innovative fermentation for improved plant protein utility. Their portfolio of products which include DBT-100 LS and DBT-100 HT , Liqui-TIDE bandage and LACTOTIDES HEALTH A+.

Dabomb Protein Biotech (ROCO:6578) Headlines

No Headlines